Evidence map›Paper›PMID 41366480›Full record

ArticleBioData mining2025

CatBoost with physics-based metaheuristics for thyroid cancer recurrence prediction.

Proshenjit Sarker, Kwonhue Choi, Abdullah-Al Nahid, Md Abdus Samad

Abstract read
In one paragraph

Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Proshenjit SarkerECE Discipline, Khulna University, Khulna, 9208, Bangladesh.
Kwonhue ChoiDepartment of Information and Communication Engineering, Yeungnam University, Gyeongsan, 38541, South Korea. gonew@yu.ac.kr.
Abdullah-Al NahidECE Discipline, Khulna University, Khulna, 9208, Bangladesh. nahid.ece.ku@gmail.com.
Md Abdus SamadDepartment of Information and Communication Engineering, Yeungnam University, Gyeongsan, 38541, South Korea. masamad@yu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid Cancer (TC) is the uncontrolled growth of carcinogenic cells in the thyroid gland, with a higher recurrence rate than other cancers. Early detection of TC recurrence (TCR) is crucial for timely intervention. This study develops machine-learning algorithms that reduce features while maintaining high performance. Previous studies on the Differentiated Thyroid Cancer Recurrence (DTCR) dataset struggled to improve performance with feature reduction, and misclassification causes remained unexplored. This work proposes three Physics-based Metaheuristic Algorithms (PBMHAs)—Energy Valley Optimization (EVOA), Equilibrium Optimization (EOA), and Electromagnetic Field Optimization (EFOA)—combined with the Categorical Boosting (CatBoost) classifier. SHAP is used to analyze feature importance. CatBoost without optimization (Only CB) achieved 95.83% Accuracy, 92.42% F-score, 96.29% Precision, and 89.27% Recall using all 16 features. After optimization, EVOA_CB reached 96.35% mean accuracy, while EOA_CB and EFOA_CB achieved 96.17%. EOA_CB excluded 11 less important features, and EFOA_CB attained the highest mean AUC of 0.994 with the lowest computational times. Additionally, this work provides insights into the factors contributing to misclassification. Using a 30:70 train-test split over 5 folds, EVOA_CB performed best on six selected features, with 96.35% Accuracy, 93.34% F-score, and 96.19% Precision. SHAP highlighted response, risk, and N as the most important features. These findings support early, efficient detection of TC recurrence with fewer features.

Indexed as

Cancer recurrenceCatBoostElectromagnetic field optimizationEnergy valley optimizationEquilibrium optimizationExplainable AIFeature selectionPhysics-based metaheuristic algorithmsSHAPThyroid cancer

Identifiers

PMID41366480
PMCPMC12687482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.